Microbot Medical Inc (NASDAQ:MBOT) — Market Cap & Net Worth
Market Cap & Net Worth: Microbot Medical Inc (MBOT)
Microbot Medical Inc (NASDAQ:MBOT) has a market capitalization of $141.03 Million ($141.03 Million) as of May 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17864 globally and #3989 in its home market, demonstrating a -3.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Microbot Medical Inc's stock price $2.10 by its total outstanding shares 67158044 (67.16 Million). Analyse cash efficiency ratio of Microbot Medical Inc to see how efficiently the company converts income to cash.
Microbot Medical Inc Market Cap History: 2015 to 2026
Microbot Medical Inc's market capitalization history from 2015 to 2026. Data shows change from $45.31 Billion to $141.03 Million (-41.95% CAGR).
Index Memberships
Microbot Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.01% | #495 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1743 of 3165 |
Weight: Microbot Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Microbot Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Microbot Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
387294.93x
Microbot Medical Inc's market cap is 387294.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $45.31 Billion | $117.00K | -$36.41 Million | 387294.93x | N/A |
Competitor Companies of MBOT by Market Capitalization
Companies near Microbot Medical Inc in the global market cap rankings as of May 5, 2026.
Key companies related to Microbot Medical Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #136 globally with a market cap of $162.57 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #250 globally with a market cap of $98.12 Billion USD ( €83.93 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #274 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #523 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #136 | Intuitive Surgical Inc | NASDAQ:ISRG | $162.57 Billion | $457.78 |
| #250 | EssilorLuxottica S. A. | PA:EL | $98.12 Billion | €181.25 |
| #274 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €88.50 |
| #523 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Microbot Medical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Microbot Medical Inc's market cap moved from $45.31 Billion to $ 141.03 Million, with a yearly change of -41.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $141.03 Million | +5.00% |
| 2025 | $134.32 Million | +78.57% |
| 2024 | $75.22 Million | -31.71% |
| 2023 | $110.14 Million | -45.51% |
| 2022 | $202.15 Million | -59.87% |
| 2021 | $503.69 Million | +8.85% |
| 2020 | $462.72 Million | -32.25% |
| 2019 | $683.00 Million | +491.28% |
| 2018 | $115.51 Million | -88.76% |
| 2017 | $1.03 Billion | -83.28% |
| 2016 | $6.14 Billion | -86.44% |
| 2015 | $45.31 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Microbot Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $141.03 Million USD |
| MoneyControl | $141.03 Million USD |
| MarketWatch | $141.03 Million USD |
| marketcap.company | $141.03 Million USD |
| Reuters | $141.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination f… Read more